What do systematic reviews say?

Corticosteroids vs placebo

• Corticosteroids for the management of cancer‐related fatigue in adults with advanced cancer 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 165 participants
  Very low

Corticosteroids vs modafinil

• Corticosteroids for the management of cancer‐related fatigue in adults with advanced cancer 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 73 participants
  Very low

Corticosteroids vs placebo

• Corticosteroids for the management of cancer‐related fatigue in adults with advanced cancer 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 118 participants
  Very low

Corticosteroids vs modafinil

• Corticosteroids for the management of cancer‐related fatigue in adults with advanced cancer 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 73 participants
  Very low

Systemic corticosteroids vs placebo

• Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults 2019 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 157 participants
  Very low

High‐dose corticosteroids vs moderate‐dose or no corticosteroids

High‐dose corticosteroids probably leads to higher serious adverse events compared with moderate‐dose or no corticosteroids (moderate certainty).

• Interventions for the treatment of metastatic extradural spinal cord compression in adults 2015 · Cochrane Headline outcomes only
  RR 8.02 [1.03, 62.37]
  2 studies · 77 participants
  Moderate

Dexamethasone vs placebo

The review found no eligible studies for this question.

• Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy,… 2017 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found